Table 2.
HLA allele | Patients | Controls | p value |
---|---|---|---|
A*01 | 22 (20.4) | 36 (14.4) | NS |
A*02 | 47 (43.5) | 108 (43.2) | NS |
A*03 | 15 (13.9) | 53 (21.2) | NS |
A*11 | 17 (15.7) | 37 (14.8) | NS |
A*23 | 10 (9.3) | 15 (6.0) | NS |
A*24 | 25 (23.1) | 72 (28.8) | NS |
A*25 | 0 | 3 (1.2) | NS |
A*26 | 7 (6.5) | 29 (11.6) | NS |
A*29 | 4 (3.7) | 13 (5.2) | NS |
A*30 | 6 (5.6) | 14 (5.6) | NS |
A*31 | 8 (7.4) | 10 (4.0) | NS |
A*32 | 12 (11.1) | 27 (10.8) | NS |
A*33 | 5 (4.6) | 11 (4.4) | NS |
A*68 | 10 (9.3) | 16 (6.4) | NS |
A*69 | 1 (0.9) | 6 (2.4) | NS |
A*74 | 0 | 1 (0.4) | NS |
Cw*01 | 10 (9.3) | 43 (17.2) | NS |
Cw*02 | 9 (8.3) | 20 (8.0) | NS |
Cw*03 | 9 (8.3) | 25 (10.0) | NS |
Cw*04 | 31 (28.7) | 85 (34.0) | NS |
Cw*05 | 16 (14.8) | 17 (6.8) | 0.016 |
Cw*06 | 24 (22.2) | 44 (17.6) | NS |
Cw*07 | 35 (32.4) | 89 (35.6) | NS |
Cw*08 | 2 (1.9) | 14 (5.6) | NS |
Cw*12 | 1 (0.9) | 1 (0.4) | NS |
Cw*17 | 1 (0.9) | 5 (2.0) | NS |
B*07 | 13 (12.0) | 29 (11.6) | NS |
B*08 | 14 (13.0) | 25 (10.0) | NS |
B*13 | 4 (3.7) | 25 (10.0) | NS |
B*18 | 16 (14.8) | 24 (9.6) | NS |
B*27 | 7 (6.5) | 15 (6.0) | NS |
B*35 | 29 (26.9) | 87 (34.8) | NS |
B*37 | 5 (4.6) | 4 (1.6) | NS |
B*38 | 6 (5.6) | 18 (7.2) | NS |
B*39 | 4 (3.7) | 5 (2.0) | NS |
B*41 | 2 (1.9) | 11 (4.4) | NS |
B*44 | 16 (14.8) | 32 (12.8) | NS |
B*45 | 0 | 5 (2.0) | NS |
B*47 | 0 | 1 (0.4) | NS |
B*48 | 0 | 5 (2.0) | NS |
B*49 | 11 (10.2) | 26 (10.4) | NS |
B*50 | 7 (6.5) | 7 (2.8) | NS |
B*51 | 25 (23.1) | 56 (22.4) | NS |
B*52 | 9 (8.3) | 20 (8.0) | NS |
B*53 | 0 | 3 (1.2) | NS |
B*54 | 0 | 3 (1.2) | NS |
B*55 | 7 (6.5) | 16 (6.4) | NS |
B*56 | 1 (0.9) | 4 (1.6) | NS |
B*57 | 6 (5.6) | 10 (4.0) | NS |
B*58 | 3 (2.8) | 6 (2.4) | NS |
B*60 | 4 (3.7) | 10 (4.0) | NS |
B*61 | 8 (7.4) | 5 (2.0) | 0.012 |
B*62 | 3 (2.8) | 3 (1.2) | NS |
B*63 | 0 | 6 (2.4) | NS |
B*64 | 0 | 2 (0.8) | NS |
B*65 | 0 | 5 (2.0) | NS |
B*71 | 1 (0.9) | 0 | NS |
B*72 | 0 | 1 (0.4) | NS |
B*75 | 2 (1.9) | 1 (0.4) | NS |
B*87 | 0 | 1 (0.4) | NS |
Values are presented as numbers (%) unless otherwise stated. MHC, major histocompatibility complex; MG, myasthenia gravis; NS, not significant.